Olmesartan-associated enteropathy

Olmesartan, an angiotensin-receptor blocker frequently prescribed for hypertension, has been commercially available since 2002. In 2012, olmesartan-associated enteropathy was described, and the Food and Drug Administration now requires a black-box warning for olmesartan regarding severe diarrhea. Th...

Full description

Saved in:
Bibliographic Details
Published in:Proc (Bayl Univ Med Cent)
Main Authors: Ebrahim, Vivian S., Martin, Jason, Murthy, Stacey, Odstrcil, Elizabeth, Huang, He, Polter, Daniel
Format: Artigo
Language:Inglês
Published: Baylor Health Care System 2017
Subjects:
Case Studies
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5468041/
https://ncbi.nlm.nih.gov/pubmed/28670083
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items